Survey Reports Changes in Pediatric Rheumatology Practice During the COVID-19 Pandemic
A group of rheumatologists and researchers analyzed how the COVID-19 pandemic has affected pediatric rheumatology practice.
Pediatrics
Golimumab Approved for Polyarticular JIA, Pediatric Psoriatic Arthritis
The FDA has approved Simponi Aria for the treatment of patients aged 2 years and older with active polyarticular juvenile idiopathic arthritis.
FDA Approves Tofacitinib for the Treatment of Active Polyarticular Course Juvenile Idiopathic Arthritis
Patients treated with tofacitinib experienced significantly fewer disease flares compared with placebo.
New Composite Disease Activity Score Assesses Systemic Manifestations of Juvenile Idiopathic Arthritis
An international panel of pediatric rheumatologists created a new score to address a lack in the 4-item JADAS in quantifying the burden of extra-articular manifestations of juvenile idiopathic arthritis.
Genetic Risk Scores May Facilitate Clinical Diagnosis of Juvenile Idiopathic Arthritis
Researchers evaluated the use and performance of genomic risk scores for the clinical diagnosis of juvenile idiopathic arthritis.
Low Rates of Severe Disease, Death Reported in Children With COVID-19
Severe disease and death appear to be rare among children and young people hospitalized with laboratory-confirmed COVID-19.
Prevalence of SARS-CoV-2 in Asymptomatic Children Identified
Prevalence of SARS-CoV-2 in asymptomatic children linked to incidence of COVID-19 in general population.
Type 2 Diabetes May Negatively Affect Bone Density in Youth
Type 2 diabetes may negatively impact bone density around the age of peak bone mass.
HHS Authorizes Pharmacists to Administer Vaccines to Children
HHS issued the amendment in order to increase access to childhood vaccines and decrease the risk of vaccine-preventable disease outbreaks as children return to daycare and school.
Combination Therapy May Benefit High-Risk Patients With Kawasaki Disease
Adding corticosteroids to initial IV immunoglobulin may reduce risk for coronary artery abnormalities.
-
Loading...
-
Loading...
Next post in Pediatric Rheumatology
